The Gujarat Kidney & Super Speciality IPO is one of the new initial public offerings opening in India this year. An IPO (Initial Public Offering) is when a company offers its shares to the public for the first time to raise money for growth and future plans.
Gujarat Kidney & Super Speciality Limited operates as a healthcare company in Gujarat, providing medical and surgical services through its network of hospitals. The company has announced its IPO with an aim to raise capital for expansion and strengthening of its business.
Basic IPO Details
The Gujarat Kidney & Super Speciality IPO is a book-built issue, which means the final price is decided through investor bidding within a price range.
Here are the basic details of the IPO:
- Price Band: ₹108 to ₹114 per share
- Face Value: ₹2 per share
- Total Issue Size: ₹250.80 crore (approx.)
- Total Shares Offered: Up to 2,20,00,000 equity shares
- Issue Type: 100% fresh issue (all money raised goes to the company)
- Lot Size: 128 shares per lot
- Listing: The shares will be listed on both BSE and NSE stock exchanges.
The IPO opens for subscription on December 22, 2025 and closes on December 24, 2025.
What the Company Does
Gujarat Kidney & Super Speciality Limited is a healthcare services provider based in Gujarat. The company runs multiple multispeciality hospitals that offer integrated healthcare services. These include general surgery, specialised medical services, diagnostics, and pharmacy services.
The hospitals serve patients in several cities across Gujarat and provide both secondary care (like surgical treatments) and tertiary care (more advanced or specialised treatments).
Who Can Invest
The IPO is open to different categories of investors:
- Retail individual investors (everyday investors)
- Non-institutional investors
- Qualified institutional buyers (like mutual funds, insurance companies)
Out of the total shares offered, a portion is reserved for each category of investors as per IPO norms.
Retail investors can apply for at least one lot of 128 shares. At the lower end of the price band, this means an investment of around ₹13,824.
Why Is the Company Raising Money?
Gujarat Kidney & Super Speciality is planning to use the money raised from this IPO to support several business objectives. These include funding new projects, expanding hospital facilities, and strengthening its services. The exact details about how the money will be allocated are usually explained in the company’s official prospectus.
Typically, companies use IPO funds for purposes such as:
- Expanding existing operations
- Acquiring new hospital facilities
- Buying new medical equipment or technology
- Reducing existing debt
- Other corporate purposes
Although the IndiaIPO page provides a general overview, the detailed implementation of these plans is part of the company’s long-term growth strategy.
Important Things for Investors to Know
Here are a few key points that investors might want to consider:
Price Range and Allotment
Investors must choose a price within the ₹108-₹114 range when applying. Shares are then allotted after the IPO closes, based on demand and other criteria.
Minimum Investment
Since the lot size is 128 shares, retail investors must invest in multiples of this number.
Listing
Once shares are allotted and credited to investor accounts, they are expected to start trading on both the BSE and NSE. The tentative listing date is usually announced closer to the IPO closing.
How Does the IPO Help the Company?
By listing on the stock exchange, Gujarat Kidney & Super Speciality gets a way to raise funds from public investors rather than relying only on loans or private funding. This can help the company grow faster, improve healthcare facilities, and potentially reach more patients across Gujarat.
Final Summary
The Gujarat Kidney & Super Speciality IPO gives investors a chance to buy shares in a regional healthcare provider that operates a network of hospitals in Gujarat. The fresh capital raised through the IPO will support growth and expansion in medical infrastructure and services. The IPO opens on December 22, 2025, with a price band of ₹108-₹114 per share, and is expected to list on both major stock exchanges in India.
